Overview
In a landmark initiative for sustainable agriculture, Embrapa Corn and Sorghum has inaugurated a pilot biofactory focused on the development of bioinputs and biological products—notably viruses and bacteria—for controlling insect pests in agricultural crops. The initiative is aimed at scaling natural alternatives to chemical insecticides, thereby improving food safety and environmental sustainability.
Facility Capabilities and Objectives
The biofactory includes a benchtop bioreactor for microbiological fermentation, supporting the development of bioinsecticides, bioinoculants, and other agriculturally beneficial microorganisms. These will be instrumental in:
- Supporting research and technical training
- Validating biotechnologies for market readiness
- Enhancing public-private collaboration in agri-biotech
Research and Innovation Focus
According to Fernando Valicente, lead researcher at Embrapa, the initiative aims to eliminate chemical residues in food by replacing traditional pesticides with natural defensives. The Embrapa Microbial Collection houses over 11,000 microbial accessions, allowing for precise targeting of crop pests through extensive testing and scaled pilot fermentation.
Embrapa targets development of two biological products annually, derived from rigorous lab research, pilot trials, and field validation. So far, 14 Embrapa-developed bioinputs are registered with Brazil’s Ministry of Agriculture and available commercially.
Strategic Context: National Bioinputs Program
As outlined by Alessandro Cruvinel, Director at Brazil’s Ministry of Agriculture, the biofactory supports the objectives of the National Bioinputs Program (launched in 2020), which aims to:
- Advance regulatory frameworks
- Promote R&D and innovation
- Expand credit access
- Enhance training and technology infrastructure
The program’s network of ten pilot biofactories, now including Embrapa Corn and Sorghum, facilitates collaborative innovation across Brazil, enhancing R&D and commercialization efficiency.
Impacts and Future Goals
- The Brazilian bioinput market is currently valued at R$5 billion, growing annually at nearly 20%
- The SmartLab/BioFabLab model is unique to Brazil and designed to support open, collaborative innovation
Notable Case: BiomaPhos
Embrapa’s co-developed bioinput BiomaPhos, based on Bacillus spp., was Brazil’s first commercial phosphate-solubilizing inoculant. It generated an estimated R$4.2 billion in benefits from 2019–2023.
Leadership Perspectives
Sara Rios, Deputy Head, Embrapa Corn and Sorghum
She underscored that the facility will strengthen open innovation ecosystems and serve as a hub for protocol development, training, and business incubation.
Frederico Durães, General Manager, Embrapa Corn and Sorghum
He emphasized the full integration of micro and macro active research for integrated pest management and biological control under Brazil’s new bioinput framework (Law No. 15,070/2024).
Conclusion
The Embrapa Biofactory represents a significant step toward self-sufficiency in agri-biotech, aligning with Brazil’s national sustainability goals, bolstering R&D infrastructure, and creating pathways for climate-resilient, inclusive agriculture.
